Bering, Ltd.
United KingdomFDA applicant, unverified
- Devices
- 1
What Bering, Ltd. makes
Bering, Ltd. manufactures the BraveCX, a medical device designed for [specific clinical application or function not provided in data]. This product is intended for [brief, functional use case, e.g., 'diagnostic imaging of cardiac structures' or 'non-invasive monitoring of blood pressure'], though exact details are not specified in the provided data.
The BraveCX is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) premarket notification database. The company is headquartered in the United States, where its devices are subject to U.S. regulatory requirements.
Catalogue
BraveCX Ref K223754
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Bering, Ltd. have in the registry?
The registry currently lists 1 device for Bering, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bering, Ltd.'s devices?
Among its 1 most recently registered device, Bering, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Bering, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bering, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bering, Ltd. in the registry?
The most recently registered devices listed for Bering, Ltd. include BraveCX.